Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drawbridge Special Opportunities Fund is a multi-strategy investment fund managed by Fortress Investment Group. The fund specializes in "special situations" and opportunistic investments, including distressed debt, undervalued assets, and structured finance across a wide range of industries. In the healthcare and life sciences sectors, the fund typically engages through credit-based investments, royalty financing, and providing liquidity to mid-to-late-stage companies. It is one of the flagship investment vehicles within the Fortress Credit platform, known for handling complex, asset-intensive transactions. The fund provides non-dilutive capital solutions to companies that may not have access to traditional capital markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drawbridge Special Opportunities Fund.